nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Convulsion—Betamethasone—hematologic cancer	0.00042	0.000475	CcSEcCtD
Betahistine—Headache—Thiotepa—hematologic cancer	0.000419	0.000474	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000419	0.000474	CcSEcCtD
Betahistine—Diarrhoea—Ifosfamide—hematologic cancer	0.000416	0.000471	CcSEcCtD
Betahistine—Nausea—Vinorelbine—hematologic cancer	0.000416	0.000471	CcSEcCtD
Betahistine—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000415	0.000469	CcSEcCtD
Betahistine—Asthenia—Mitoxantrone—hematologic cancer	0.000414	0.000469	CcSEcCtD
Betahistine—Asthenia—Irinotecan—hematologic cancer	0.000414	0.000469	CcSEcCtD
Betahistine—Fatigue—Etoposide—hematologic cancer	0.000414	0.000469	CcSEcCtD
Betahistine—Vomiting—Thalidomide—hematologic cancer	0.000411	0.000465	CcSEcCtD
Betahistine—Dizziness—Carmustine—hematologic cancer	0.000411	0.000465	CcSEcCtD
Betahistine—Rash—Thalidomide—hematologic cancer	0.000408	0.000462	CcSEcCtD
Betahistine—Discomfort—Dexamethasone—hematologic cancer	0.000407	0.000461	CcSEcCtD
Betahistine—Discomfort—Betamethasone—hematologic cancer	0.000407	0.000461	CcSEcCtD
Betahistine—Dermatitis—Thalidomide—hematologic cancer	0.000407	0.000461	CcSEcCtD
Betahistine—Dizziness—Alitretinoin—hematologic cancer	0.000407	0.000461	CcSEcCtD
Betahistine—Diarrhoea—Vincristine—hematologic cancer	0.000406	0.000459	CcSEcCtD
Betahistine—Headache—Thalidomide—hematologic cancer	0.000405	0.000459	CcSEcCtD
Betahistine—Asthenia—Gemcitabine—hematologic cancer	0.000404	0.000457	CcSEcCtD
Betahistine—Dizziness—Ifosfamide—hematologic cancer	0.000402	0.000455	CcSEcCtD
Betahistine—Pruritus—Gemcitabine—hematologic cancer	0.000398	0.00045	CcSEcCtD
Betahistine—Nausea—Thiotepa—hematologic cancer	0.000397	0.00045	CcSEcCtD
Betahistine—Feeling abnormal—Etoposide—hematologic cancer	0.000396	0.000448	CcSEcCtD
Betahistine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000395	0.000447	CcSEcCtD
Betahistine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000395	0.000447	CcSEcCtD
Betahistine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000395	0.000447	CcSEcCtD
Betahistine—Diarrhoea—Irinotecan—hematologic cancer	0.000395	0.000447	CcSEcCtD
Betahistine—Vomiting—Carmustine—hematologic cancer	0.000395	0.000447	CcSEcCtD
Betahistine—Dizziness—Vincristine—hematologic cancer	0.000392	0.000444	CcSEcCtD
Betahistine—Rash—Carmustine—hematologic cancer	0.000392	0.000443	CcSEcCtD
Betahistine—Ill-defined disorder—Prednisone—hematologic cancer	0.000391	0.000443	CcSEcCtD
Betahistine—Dermatitis—Carmustine—hematologic cancer	0.000391	0.000443	CcSEcCtD
Betahistine—Vomiting—Alitretinoin—hematologic cancer	0.000391	0.000443	CcSEcCtD
Betahistine—Feeling abnormal—Prednisolone—hematologic cancer	0.00039	0.000442	CcSEcCtD
Betahistine—Headache—Carmustine—hematologic cancer	0.000389	0.00044	CcSEcCtD
Betahistine—Dyspnoea—Triamcinolone—hematologic cancer	0.000388	0.00044	CcSEcCtD
Betahistine—Rash—Alitretinoin—hematologic cancer	0.000388	0.000439	CcSEcCtD
Betahistine—Nervous system disorder—Betamethasone—hematologic cancer	0.000388	0.000439	CcSEcCtD
Betahistine—Nervous system disorder—Dexamethasone—hematologic cancer	0.000388	0.000439	CcSEcCtD
Betahistine—Dermatitis—Alitretinoin—hematologic cancer	0.000388	0.000439	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000387	0.000438	CcSEcCtD
Betahistine—Vomiting—Ifosfamide—hematologic cancer	0.000387	0.000438	CcSEcCtD
Betahistine—Hypersensitivity—Cisplatin—hematologic cancer	0.000386	0.000437	CcSEcCtD
Betahistine—Tachycardia—Dexamethasone—hematologic cancer	0.000386	0.000437	CcSEcCtD
Betahistine—Tachycardia—Betamethasone—hematologic cancer	0.000386	0.000437	CcSEcCtD
Betahistine—Headache—Alitretinoin—hematologic cancer	0.000385	0.000436	CcSEcCtD
Betahistine—Angioedema—Prednisone—hematologic cancer	0.000385	0.000436	CcSEcCtD
Betahistine—Diarrhoea—Gemcitabine—hematologic cancer	0.000385	0.000436	CcSEcCtD
Betahistine—Nausea—Thalidomide—hematologic cancer	0.000384	0.000435	CcSEcCtD
Betahistine—Dyspepsia—Triamcinolone—hematologic cancer	0.000383	0.000434	CcSEcCtD
Betahistine—Rash—Ifosfamide—hematologic cancer	0.000383	0.000434	CcSEcCtD
Betahistine—Dermatitis—Ifosfamide—hematologic cancer	0.000383	0.000434	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—hematologic cancer	0.000383	0.000433	CcSEcCtD
Betahistine—Dizziness—Irinotecan—hematologic cancer	0.000382	0.000432	CcSEcCtD
Betahistine—Urticaria—Etoposide—hematologic cancer	0.000382	0.000432	CcSEcCtD
Betahistine—Malaise—Prednisone—hematologic cancer	0.00038	0.000431	CcSEcCtD
Betahistine—Vomiting—Vincristine—hematologic cancer	0.000377	0.000427	CcSEcCtD
Betahistine—Urticaria—Prednisolone—hematologic cancer	0.000376	0.000426	CcSEcCtD
Betahistine—Asthenia—Cisplatin—hematologic cancer	0.000376	0.000426	CcSEcCtD
Betahistine—Fatigue—Triamcinolone—hematologic cancer	0.000376	0.000425	CcSEcCtD
Betahistine—Rash—Vincristine—hematologic cancer	0.000374	0.000423	CcSEcCtD
Betahistine—Dermatitis—Vincristine—hematologic cancer	0.000374	0.000423	CcSEcCtD
Betahistine—Headache—Vincristine—hematologic cancer	0.000371	0.00042	CcSEcCtD
Betahistine—Nausea—Carmustine—hematologic cancer	0.000369	0.000418	CcSEcCtD
Betahistine—Vomiting—Mitoxantrone—hematologic cancer	0.000367	0.000416	CcSEcCtD
Betahistine—Vomiting—Irinotecan—hematologic cancer	0.000367	0.000416	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—hematologic cancer	0.000366	0.000414	CcSEcCtD
Betahistine—Nausea—Alitretinoin—hematologic cancer	0.000365	0.000414	CcSEcCtD
Betahistine—Convulsion—Prednisone—hematologic cancer	0.000365	0.000414	CcSEcCtD
Betahistine—Rash—Mitoxantrone—hematologic cancer	0.000364	0.000412	CcSEcCtD
Betahistine—Rash—Irinotecan—hematologic cancer	0.000364	0.000412	CcSEcCtD
Betahistine—Dermatitis—Mitoxantrone—hematologic cancer	0.000364	0.000412	CcSEcCtD
Betahistine—Dermatitis—Irinotecan—hematologic cancer	0.000364	0.000412	CcSEcCtD
Betahistine—Headache—Irinotecan—hematologic cancer	0.000362	0.000409	CcSEcCtD
Betahistine—Headache—Mitoxantrone—hematologic cancer	0.000362	0.000409	CcSEcCtD
Betahistine—Nausea—Ifosfamide—hematologic cancer	0.000361	0.000409	CcSEcCtD
Betahistine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000359	0.000406	CcSEcCtD
Betahistine—Diarrhoea—Cisplatin—hematologic cancer	0.000359	0.000406	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—hematologic cancer	0.000358	0.000406	CcSEcCtD
Betahistine—Vomiting—Gemcitabine—hematologic cancer	0.000358	0.000405	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000357	0.000404	CcSEcCtD
Betahistine—Discomfort—Prednisone—hematologic cancer	0.000355	0.000402	CcSEcCtD
Betahistine—Rash—Gemcitabine—hematologic cancer	0.000355	0.000401	CcSEcCtD
Betahistine—Dermatitis—Gemcitabine—hematologic cancer	0.000354	0.000401	CcSEcCtD
Betahistine—Hypersensitivity—Etoposide—hematologic cancer	0.000354	0.000401	CcSEcCtD
Betahistine—Headache—Gemcitabine—hematologic cancer	0.000352	0.000399	CcSEcCtD
Betahistine—Nausea—Vincristine—hematologic cancer	0.000352	0.000399	CcSEcCtD
Betahistine—Hypersensitivity—Prednisolone—hematologic cancer	0.000349	0.000395	CcSEcCtD
Betahistine—Dyspepsia—Dexamethasone—hematologic cancer	0.000348	0.000394	CcSEcCtD
Betahistine—Dyspepsia—Betamethasone—hematologic cancer	0.000348	0.000394	CcSEcCtD
Betahistine—Urticaria—Triamcinolone—hematologic cancer	0.000346	0.000392	CcSEcCtD
Betahistine—Asthenia—Etoposide—hematologic cancer	0.000345	0.00039	CcSEcCtD
Betahistine—Anaphylactic shock—Prednisone—hematologic cancer	0.000344	0.00039	CcSEcCtD
Betahistine—Nausea—Mitoxantrone—hematologic cancer	0.000343	0.000388	CcSEcCtD
Betahistine—Nausea—Irinotecan—hematologic cancer	0.000343	0.000388	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—hematologic cancer	0.000342	0.000387	CcSEcCtD
Betahistine—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000341	0.000386	CcSEcCtD
Betahistine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000341	0.000386	CcSEcCtD
Betahistine—Fatigue—Betamethasone—hematologic cancer	0.000341	0.000386	CcSEcCtD
Betahistine—Fatigue—Dexamethasone—hematologic cancer	0.000341	0.000386	CcSEcCtD
Betahistine—Pruritus—Etoposide—hematologic cancer	0.00034	0.000385	CcSEcCtD
Betahistine—Nervous system disorder—Prednisone—hematologic cancer	0.000338	0.000382	CcSEcCtD
Betahistine—Tachycardia—Prednisone—hematologic cancer	0.000336	0.00038	CcSEcCtD
Betahistine—Skin disorder—Prednisone—hematologic cancer	0.000334	0.000378	CcSEcCtD
Betahistine—Nausea—Gemcitabine—hematologic cancer	0.000334	0.000378	CcSEcCtD
Betahistine—Vomiting—Cisplatin—hematologic cancer	0.000333	0.000377	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—hematologic cancer	0.000332	0.000375	CcSEcCtD
Betahistine—Rash—Cisplatin—hematologic cancer	0.000331	0.000374	CcSEcCtD
Betahistine—Dermatitis—Cisplatin—hematologic cancer	0.00033	0.000374	CcSEcCtD
Betahistine—Diarrhoea—Etoposide—hematologic cancer	0.000329	0.000372	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—hematologic cancer	0.000327	0.00037	CcSEcCtD
Betahistine—Feeling abnormal—Betamethasone—hematologic cancer	0.000326	0.000369	CcSEcCtD
Betahistine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000326	0.000369	CcSEcCtD
Betahistine—Flatulence—Epirubicin—hematologic cancer	0.000325	0.000368	CcSEcCtD
Betahistine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000321	0.000363	CcSEcCtD
Betahistine—Malaise—Methotrexate—hematologic cancer	0.000318	0.00036	CcSEcCtD
Betahistine—Dizziness—Etoposide—hematologic cancer	0.000318	0.000359	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—hematologic cancer	0.000317	0.000358	CcSEcCtD
Betahistine—Urticaria—Dexamethasone—hematologic cancer	0.000314	0.000355	CcSEcCtD
Betahistine—Urticaria—Betamethasone—hematologic cancer	0.000314	0.000355	CcSEcCtD
Betahistine—Dizziness—Prednisolone—hematologic cancer	0.000313	0.000355	CcSEcCtD
Betahistine—Asthenia—Triamcinolone—hematologic cancer	0.000313	0.000354	CcSEcCtD
Betahistine—Nausea—Cisplatin—hematologic cancer	0.000311	0.000352	CcSEcCtD
Betahistine—Pruritus—Triamcinolone—hematologic cancer	0.000308	0.000349	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—hematologic cancer	0.000306	0.000346	CcSEcCtD
Betahistine—Convulsion—Methotrexate—hematologic cancer	0.000305	0.000346	CcSEcCtD
Betahistine—Vomiting—Etoposide—hematologic cancer	0.000305	0.000346	CcSEcCtD
Betahistine—Dyspepsia—Prednisone—hematologic cancer	0.000303	0.000343	CcSEcCtD
Betahistine—Rash—Etoposide—hematologic cancer	0.000303	0.000343	CcSEcCtD
Betahistine—Dermatitis—Etoposide—hematologic cancer	0.000303	0.000342	CcSEcCtD
Betahistine—Headache—Etoposide—hematologic cancer	0.000301	0.000341	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—hematologic cancer	0.000301	0.00034	CcSEcCtD
Betahistine—Rash—Prednisolone—hematologic cancer	0.000299	0.000338	CcSEcCtD
Betahistine—Dermatitis—Prednisolone—hematologic cancer	0.000298	0.000338	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000298	0.000337	CcSEcCtD
Betahistine—Malaise—Epirubicin—hematologic cancer	0.000297	0.000337	CcSEcCtD
Betahistine—Fatigue—Prednisone—hematologic cancer	0.000297	0.000336	CcSEcCtD
Betahistine—Headache—Prednisolone—hematologic cancer	0.000297	0.000336	CcSEcCtD
Betahistine—Discomfort—Methotrexate—hematologic cancer	0.000297	0.000336	CcSEcCtD
Betahistine—Confusional state—Methotrexate—hematologic cancer	0.00029	0.000328	CcSEcCtD
Betahistine—Dizziness—Triamcinolone—hematologic cancer	0.000288	0.000326	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000288	0.000326	CcSEcCtD
Betahistine—Convulsion—Epirubicin—hematologic cancer	0.000286	0.000324	CcSEcCtD
Betahistine—Nausea—Etoposide—hematologic cancer	0.000285	0.000323	CcSEcCtD
Betahistine—Feeling abnormal—Prednisone—hematologic cancer	0.000284	0.000321	CcSEcCtD
Betahistine—Asthenia—Dexamethasone—hematologic cancer	0.000284	0.000321	CcSEcCtD
Betahistine—Asthenia—Betamethasone—hematologic cancer	0.000284	0.000321	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—hematologic cancer	0.000283	0.000321	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—hematologic cancer	0.000282	0.000319	CcSEcCtD
Betahistine—Nausea—Prednisolone—hematologic cancer	0.000281	0.000318	CcSEcCtD
Betahistine—Pruritus—Dexamethasone—hematologic cancer	0.00028	0.000317	CcSEcCtD
Betahistine—Pruritus—Betamethasone—hematologic cancer	0.00028	0.000317	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—hematologic cancer	0.000279	0.000316	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000279	0.000316	CcSEcCtD
Betahistine—Discomfort—Epirubicin—hematologic cancer	0.000277	0.000314	CcSEcCtD
Betahistine—Vomiting—Triamcinolone—hematologic cancer	0.000277	0.000314	CcSEcCtD
Betahistine—Malaise—Doxorubicin—hematologic cancer	0.000275	0.000312	CcSEcCtD
Betahistine—Rash—Triamcinolone—hematologic cancer	0.000275	0.000311	CcSEcCtD
Betahistine—Dermatitis—Triamcinolone—hematologic cancer	0.000274	0.000311	CcSEcCtD
Betahistine—Urticaria—Prednisone—hematologic cancer	0.000273	0.00031	CcSEcCtD
Betahistine—Headache—Triamcinolone—hematologic cancer	0.000273	0.000309	CcSEcCtD
Betahistine—Confusional state—Epirubicin—hematologic cancer	0.000271	0.000307	CcSEcCtD
Betahistine—Diarrhoea—Betamethasone—hematologic cancer	0.00027	0.000306	CcSEcCtD
Betahistine—Diarrhoea—Dexamethasone—hematologic cancer	0.00027	0.000306	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000269	0.000305	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—hematologic cancer	0.000264	0.000299	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—hematologic cancer	0.000264	0.000299	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—hematologic cancer	0.000263	0.000297	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—hematologic cancer	0.000262	0.000296	CcSEcCtD
Betahistine—Dizziness—Betamethasone—hematologic cancer	0.000261	0.000296	CcSEcCtD
Betahistine—Dizziness—Dexamethasone—hematologic cancer	0.000261	0.000296	CcSEcCtD
Betahistine—Nausea—Triamcinolone—hematologic cancer	0.000259	0.000293	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000258	0.000292	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—hematologic cancer	0.000257	0.000291	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—hematologic cancer	0.000256	0.00029	CcSEcCtD
Betahistine—Somnolence—Methotrexate—hematologic cancer	0.000256	0.000289	CcSEcCtD
Betahistine—Hypersensitivity—Prednisone—hematologic cancer	0.000254	0.000287	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—hematologic cancer	0.000253	0.000287	CcSEcCtD
Betahistine—Vomiting—Betamethasone—hematologic cancer	0.000251	0.000284	CcSEcCtD
Betahistine—Vomiting—Dexamethasone—hematologic cancer	0.000251	0.000284	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—hematologic cancer	0.000251	0.000284	CcSEcCtD
Betahistine—Rash—Betamethasone—hematologic cancer	0.000249	0.000282	CcSEcCtD
Betahistine—Rash—Dexamethasone—hematologic cancer	0.000249	0.000282	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000249	0.000282	CcSEcCtD
Betahistine—Dermatitis—Betamethasone—hematologic cancer	0.000249	0.000282	CcSEcCtD
Betahistine—Dermatitis—Dexamethasone—hematologic cancer	0.000249	0.000282	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000248	0.000281	CcSEcCtD
Betahistine—Fatigue—Methotrexate—hematologic cancer	0.000248	0.000281	CcSEcCtD
Betahistine—Headache—Dexamethasone—hematologic cancer	0.000248	0.00028	CcSEcCtD
Betahistine—Headache—Betamethasone—hematologic cancer	0.000248	0.00028	CcSEcCtD
Betahistine—Asthenia—Prednisone—hematologic cancer	0.000247	0.00028	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—hematologic cancer	0.000244	0.000277	CcSEcCtD
Betahistine—Pruritus—Prednisone—hematologic cancer	0.000244	0.000276	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—hematologic cancer	0.000243	0.000275	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—hematologic cancer	0.000242	0.000274	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—hematologic cancer	0.00024	0.000272	CcSEcCtD
Betahistine—Somnolence—Epirubicin—hematologic cancer	0.000239	0.000271	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—hematologic cancer	0.000237	0.000268	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—hematologic cancer	0.000237	0.000268	CcSEcCtD
Betahistine—Diarrhoea—Prednisone—hematologic cancer	0.000236	0.000267	CcSEcCtD
Betahistine—Nausea—Dexamethasone—hematologic cancer	0.000235	0.000266	CcSEcCtD
Betahistine—Nausea—Betamethasone—hematologic cancer	0.000235	0.000266	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000232	0.000263	CcSEcCtD
Betahistine—Fatigue—Epirubicin—hematologic cancer	0.000232	0.000263	CcSEcCtD
Betahistine—Urticaria—Methotrexate—hematologic cancer	0.000229	0.000259	CcSEcCtD
Betahistine—Dizziness—Prednisone—hematologic cancer	0.000228	0.000258	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—hematologic cancer	0.000222	0.000251	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—hematologic cancer	0.000222	0.000251	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—hematologic cancer	0.000221	0.000251	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—hematologic cancer	0.000219	0.000248	CcSEcCtD
Betahistine—Vomiting—Prednisone—hematologic cancer	0.000219	0.000248	CcSEcCtD
Betahistine—Rash—Prednisone—hematologic cancer	0.000217	0.000246	CcSEcCtD
Betahistine—Dermatitis—Prednisone—hematologic cancer	0.000217	0.000245	CcSEcCtD
Betahistine—Headache—Prednisone—hematologic cancer	0.000216	0.000244	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000215	0.000243	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—hematologic cancer	0.000215	0.000243	CcSEcCtD
Betahistine—Urticaria—Epirubicin—hematologic cancer	0.000214	0.000242	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—hematologic cancer	0.000212	0.00024	CcSEcCtD
Betahistine—Asthenia—Methotrexate—hematologic cancer	0.000206	0.000234	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—hematologic cancer	0.000205	0.000232	CcSEcCtD
Betahistine—Nausea—Prednisone—hematologic cancer	0.000204	0.000231	CcSEcCtD
Betahistine—Pruritus—Methotrexate—hematologic cancer	0.000204	0.00023	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—hematologic cancer	0.000198	0.000225	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—hematologic cancer	0.000198	0.000224	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—hematologic cancer	0.000197	0.000223	CcSEcCtD
Betahistine—Asthenia—Epirubicin—hematologic cancer	0.000193	0.000219	CcSEcCtD
Betahistine—Pruritus—Epirubicin—hematologic cancer	0.00019	0.000216	CcSEcCtD
Betahistine—Dizziness—Methotrexate—hematologic cancer	0.00019	0.000215	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—hematologic cancer	0.000184	0.000208	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000184	0.000208	CcSEcCtD
Betahistine—Vomiting—Methotrexate—hematologic cancer	0.000183	0.000207	CcSEcCtD
Betahistine—Rash—Methotrexate—hematologic cancer	0.000181	0.000205	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—hematologic cancer	0.000181	0.000205	CcSEcCtD
Betahistine—Headache—Methotrexate—hematologic cancer	0.00018	0.000204	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—hematologic cancer	0.000179	0.000202	CcSEcCtD
Betahistine—Dizziness—Epirubicin—hematologic cancer	0.000178	0.000202	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—hematologic cancer	0.000176	0.000199	CcSEcCtD
Betahistine—Vomiting—Epirubicin—hematologic cancer	0.000171	0.000194	CcSEcCtD
Betahistine—Nausea—Methotrexate—hematologic cancer	0.000171	0.000193	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—hematologic cancer	0.00017	0.000193	CcSEcCtD
Betahistine—Rash—Epirubicin—hematologic cancer	0.00017	0.000192	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—hematologic cancer	0.00017	0.000192	CcSEcCtD
Betahistine—Headache—Epirubicin—hematologic cancer	0.000169	0.000191	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—hematologic cancer	0.000165	0.000186	CcSEcCtD
Betahistine—Nausea—Epirubicin—hematologic cancer	0.00016	0.000181	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—hematologic cancer	0.000158	0.000179	CcSEcCtD
Betahistine—Rash—Doxorubicin—hematologic cancer	0.000157	0.000178	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—hematologic cancer	0.000157	0.000178	CcSEcCtD
Betahistine—Headache—Doxorubicin—hematologic cancer	0.000156	0.000177	CcSEcCtD
Betahistine—Nausea—Doxorubicin—hematologic cancer	0.000148	0.000167	CcSEcCtD
Betahistine—HRH1—Signaling by GPCR—CNR2—hematologic cancer	9.73e-05	0.000835	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HES1—hematologic cancer	9.7e-05	0.000833	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NCOR1—hematologic cancer	9.64e-05	0.000828	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RAC2—hematologic cancer	9.57e-05	0.000822	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	9.54e-05	0.000819	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGF1—hematologic cancer	9.53e-05	0.000819	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CSF2—hematologic cancer	9.53e-05	0.000819	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FOXO1—hematologic cancer	9.4e-05	0.000807	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—IL2—hematologic cancer	9.39e-05	0.000806	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PDGFRB—hematologic cancer	9.38e-05	0.000805	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CB—hematologic cancer	9.29e-05	0.000797	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PDGFRA—hematologic cancer	9.23e-05	0.000793	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKCG—hematologic cancer	9.2e-05	0.00079	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—JAK1—hematologic cancer	9.2e-05	0.00079	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ARHGEF12—hematologic cancer	9.15e-05	0.000786	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADCY7—hematologic cancer	9.15e-05	0.000785	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTHLH—hematologic cancer	9.11e-05	0.000782	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ARHGEF1—hematologic cancer	8.92e-05	0.000766	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTGER4—hematologic cancer	8.87e-05	0.000761	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2RA—hematologic cancer	8.59e-05	0.000738	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL2—hematologic cancer	8.53e-05	0.000732	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TERT—hematologic cancer	8.5e-05	0.00073	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL3—hematologic cancer	8.37e-05	0.000718	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PDGFB—hematologic cancer	8.29e-05	0.000712	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTHLH—hematologic cancer	8.27e-05	0.00071	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—hematologic cancer	8.17e-05	0.000702	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TSC2—hematologic cancer	8.11e-05	0.000696	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTGER4—hematologic cancer	8.05e-05	0.000692	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGRN—hematologic cancer	8e-05	0.000687	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL17—hematologic cancer	8e-05	0.000687	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR5—hematologic cancer	7.85e-05	0.000674	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCR4—hematologic cancer	7.83e-05	0.000673	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—hematologic cancer	7.83e-05	0.000672	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGFR3—hematologic cancer	7.8e-05	0.000669	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK14—hematologic cancer	7.72e-05	0.000663	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEF1—hematologic cancer	7.71e-05	0.000662	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNA13—hematologic cancer	7.58e-05	0.000651	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ESR1—hematologic cancer	7.57e-05	0.00065	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL3—hematologic cancer	7.55e-05	0.000649	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FN1—hematologic cancer	7.48e-05	0.000642	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TIAM1—hematologic cancer	7.46e-05	0.000641	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—BAD—hematologic cancer	7.39e-05	0.000635	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NFKBIA—hematologic cancer	7.39e-05	0.000635	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOTCH1—hematologic cancer	7.32e-05	0.000629	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RASGRP1—hematologic cancer	7.31e-05	0.000627	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL2—hematologic cancer	7.27e-05	0.000624	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAK3—hematologic cancer	7.24e-05	0.000621	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PIK3CA—hematologic cancer	7.23e-05	0.00062	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CD80—hematologic cancer	7.17e-05	0.000616	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CG—hematologic cancer	7.16e-05	0.000615	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KIT—hematologic cancer	7.16e-05	0.000615	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—NRAS—hematologic cancer	7.16e-05	0.000615	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR4—hematologic cancer	7.11e-05	0.000611	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—hematologic cancer	7.03e-05	0.000604	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTPN11—hematologic cancer	7.03e-05	0.000604	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL13—hematologic cancer	6.94e-05	0.000596	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR7—hematologic cancer	6.94e-05	0.000596	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL3—hematologic cancer	6.86e-05	0.000589	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK3—hematologic cancer	6.86e-05	0.000589	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NCOR2—hematologic cancer	6.85e-05	0.000588	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CREB1—hematologic cancer	6.81e-05	0.000585	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL3RA—hematologic cancer	6.76e-05	0.00058	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CRKL—hematologic cancer	6.76e-05	0.00058	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—BRAF—hematologic cancer	6.73e-05	0.000578	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL2—hematologic cancer	6.67e-05	0.000572	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6R—hematologic cancer	6.65e-05	0.000571	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CREBBP—hematologic cancer	6.64e-05	0.00057	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RASGRP1—hematologic cancer	6.63e-05	0.00057	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GRB2—hematologic cancer	6.57e-05	0.000564	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RGS2—hematologic cancer	6.52e-05	0.00056	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	6.46e-05	0.000555	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CMA1—hematologic cancer	6.45e-05	0.000554	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TRH—hematologic cancer	6.45e-05	0.000554	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TRIO—hematologic cancer	6.45e-05	0.000554	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAP2K1—hematologic cancer	6.34e-05	0.000544	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGO2—hematologic cancer	6.31e-05	0.000542	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SPHK1—hematologic cancer	6.31e-05	0.000542	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CD—hematologic cancer	6.29e-05	0.00054	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HDAC9—hematologic cancer	6.25e-05	0.000536	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LPAR1—hematologic cancer	6.25e-05	0.000536	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CA—hematologic cancer	6.23e-05	0.000535	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—H3F3B—hematologic cancer	6.18e-05	0.000531	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—KRAS—hematologic cancer	6.16e-05	0.000529	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGF2—hematologic cancer	6.03e-05	0.000517	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	5.98e-05	0.000513	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GRB2—hematologic cancer	5.97e-05	0.000512	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3R1—hematologic cancer	5.94e-05	0.00051	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CSF2—hematologic cancer	5.87e-05	0.000504	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—JAK2—hematologic cancer	5.78e-05	0.000496	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CNR2—hematologic cancer	5.75e-05	0.000494	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDE4B—hematologic cancer	5.75e-05	0.000494	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	5.72e-05	0.000491	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF19—hematologic cancer	5.7e-05	0.000489	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PRKCG—hematologic cancer	5.67e-05	0.000487	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—JAK1—hematologic cancer	5.67e-05	0.000487	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CA—hematologic cancer	5.66e-05	0.000486	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RAC2—hematologic cancer	5.65e-05	0.000486	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MDM2—hematologic cancer	5.64e-05	0.000484	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—DKK1—hematologic cancer	5.61e-05	0.000482	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT5B—hematologic cancer	5.57e-05	0.000478	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MTOR—hematologic cancer	5.49e-05	0.000471	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CB—hematologic cancer	5.49e-05	0.000471	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADCY7—hematologic cancer	5.4e-05	0.000464	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CSF2—hematologic cancer	5.33e-05	0.000458	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2RA—hematologic cancer	5.29e-05	0.000454	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—XIAP—hematologic cancer	5.26e-05	0.000451	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—HRAS—hematologic cancer	5.24e-05	0.00045	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1B—hematologic cancer	5.15e-05	0.000442	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—JAK1—hematologic cancer	5.15e-05	0.000442	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRKCG—hematologic cancer	5.15e-05	0.000442	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SMARCA4—hematologic cancer	5.12e-05	0.00044	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SH2B3—hematologic cancer	5.12e-05	0.00044	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT1—hematologic cancer	5.09e-05	0.000437	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GZMB—hematologic cancer	5.09e-05	0.000437	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASP3—hematologic cancer	5.05e-05	0.000433	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2—hematologic cancer	5.04e-05	0.000433	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—hematologic cancer	5.01e-05	0.00043	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CTNNA1—hematologic cancer	4.97e-05	0.000427	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EIF4EBP1—hematologic cancer	4.94e-05	0.000424	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HSPB1—hematologic cancer	4.94e-05	0.000424	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL3—hematologic cancer	4.94e-05	0.000424	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCND1—hematologic cancer	4.91e-05	0.000422	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—JUN—hematologic cancer	4.9e-05	0.000421	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTHLH—hematologic cancer	4.89e-05	0.00042	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SDC1—hematologic cancer	4.89e-05	0.00042	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2RA—hematologic cancer	4.81e-05	0.000413	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTGER4—hematologic cancer	4.76e-05	0.000409	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1A—hematologic cancer	4.75e-05	0.000408	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTEN—hematologic cancer	4.74e-05	0.000407	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LCK—hematologic cancer	4.73e-05	0.000406	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—H3F3A—hematologic cancer	4.64e-05	0.000398	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK8—hematologic cancer	4.64e-05	0.000398	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT1—hematologic cancer	4.62e-05	0.000397	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EP300—hematologic cancer	4.52e-05	0.000388	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCZ—hematologic cancer	4.51e-05	0.000387	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	4.41e-05	0.000379	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SRC—hematologic cancer	4.4e-05	0.000377	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PARP1—hematologic cancer	4.36e-05	0.000374	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FBXW7—hematologic cancer	4.29e-05	0.000368	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—hematologic cancer	4.28e-05	0.000368	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—hematologic cancer	4.24e-05	0.000364	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NRAS—hematologic cancer	4.23e-05	0.000363	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HDAC2—hematologic cancer	4.2e-05	0.000361	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR4—hematologic cancer	4.2e-05	0.000361	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CBL—hematologic cancer	4.1e-05	0.000352	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL3—hematologic cancer	4.05e-05	0.000348	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK3—hematologic cancer	4.05e-05	0.000348	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	4e-05	0.000344	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTPN1—hematologic cancer	3.98e-05	0.000342	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MYC—hematologic cancer	3.94e-05	0.000338	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	3.93e-05	0.000338	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFB1—hematologic cancer	3.93e-05	0.000337	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	3.92e-05	0.000337	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	3.91e-05	0.000335	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SYK—hematologic cancer	3.91e-05	0.000335	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	3.88e-05	0.000333	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CREB1—hematologic cancer	3.81e-05	0.000327	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT1—hematologic cancer	3.77e-05	0.000323	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL2—hematologic cancer	3.73e-05	0.00032	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6R—hematologic cancer	3.72e-05	0.000319	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	3.66e-05	0.000314	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KRAS—hematologic cancer	3.64e-05	0.000313	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	3.56e-05	0.000305	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	3.54e-05	0.000304	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRB2—hematologic cancer	3.52e-05	0.000303	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	3.52e-05	0.000302	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	3.52e-05	0.000302	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KITLG—hematologic cancer	3.47e-05	0.000298	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	3.39e-05	0.000291	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.38e-05	0.00029	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	3.36e-05	0.000288	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CA—hematologic cancer	3.34e-05	0.000287	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	3.32e-05	0.000285	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CD86—hematologic cancer	3.25e-05	0.000279	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TP53—hematologic cancer	3.24e-05	0.000278	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	3.23e-05	0.000277	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HES1—hematologic cancer	3.2e-05	0.000275	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	3.18e-05	0.000273	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF1—hematologic cancer	3.15e-05	0.00027	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CSF2—hematologic cancer	3.15e-05	0.00027	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	3.1e-05	0.000266	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	3.1e-05	0.000266	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	3.1e-05	0.000266	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HRAS—hematologic cancer	3.09e-05	0.000266	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	3.07e-05	0.000263	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	3.05e-05	0.000262	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAK1—hematologic cancer	3.04e-05	0.000261	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	3.04e-05	0.000261	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—hematologic cancer	2.96e-05	0.000254	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	2.84e-05	0.000244	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2—hematologic cancer	2.82e-05	0.000242	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TERT—hematologic cancer	2.81e-05	0.000241	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	2.74e-05	0.000235	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT1—hematologic cancer	2.73e-05	0.000235	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TSC2—hematologic cancer	2.68e-05	0.00023	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	2.58e-05	0.000221	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	2.55e-05	0.000219	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ESR1—hematologic cancer	2.5e-05	0.000215	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FN1—hematologic cancer	2.47e-05	0.000212	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	2.44e-05	0.00021	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BAD—hematologic cancer	2.44e-05	0.00021	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	2.42e-05	0.000208	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CD80—hematologic cancer	2.37e-05	0.000203	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	2.36e-05	0.000203	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KIT—hematologic cancer	2.36e-05	0.000203	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	2.36e-05	0.000203	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	2.32e-05	0.000199	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	2.26e-05	0.000194	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CREB1—hematologic cancer	2.25e-05	0.000193	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BRAF—hematologic cancer	2.22e-05	0.000191	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL2—hematologic cancer	2.2e-05	0.000189	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6R—hematologic cancer	2.2e-05	0.000189	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	2.19e-05	0.000188	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	2.09e-05	0.00018	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	2.08e-05	0.000179	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.06e-05	0.000177	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	2.04e-05	0.000175	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF2—hematologic cancer	1.99e-05	0.000171	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	1.96e-05	0.000169	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAK2—hematologic cancer	1.91e-05	0.000164	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	1.87e-05	0.000161	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MDM2—hematologic cancer	1.86e-05	0.00016	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	1.81e-05	0.000156	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MTOR—hematologic cancer	1.81e-05	0.000156	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	1.73e-05	0.000149	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	1.7e-05	0.000146	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	1.68e-05	0.000144	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASP3—hematologic cancer	1.67e-05	0.000143	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2—hematologic cancer	1.66e-05	0.000143	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—hematologic cancer	1.66e-05	0.000142	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCND1—hematologic cancer	1.62e-05	0.000139	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JUN—hematologic cancer	1.62e-05	0.000139	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	1.57e-05	0.000135	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTEN—hematologic cancer	1.57e-05	0.000134	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.53e-05	0.000132	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.53e-05	0.000131	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.49e-05	0.000128	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.45e-05	0.000125	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.41e-05	0.000121	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.4e-05	0.00012	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.4e-05	0.00012	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.34e-05	0.000115	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.3e-05	0.000112	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.3e-05	0.000111	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.2e-05	0.000103	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.1e-05	9.48e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.07e-05	9.18e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.02e-05	8.78e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—hematologic cancer	9.78e-06	8.4e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT1—hematologic cancer	9.02e-06	7.75e-05	CbGpPWpGaD
